Terrie Curran
2023
In 2023, Terrie Curran earned a total compensation of $3.4M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $518,152 |
|---|---|
| Option Awards | $830,538 |
| Salary | $687,500 |
| Stock Awards | $1,357,957 |
| Other | $16,875 |
| Total | $3,411,022 |
Curran received $1.4M in stock awards, accounting for 40% of the total pay in 2023.
Curran also received $518.2K in non-equity incentive plan, $830.5K in option awards, $687.5K in salary and $16.9K in other compensation.
Rankings
In 2023, Terrie Curran's compensation ranked 240th out of 2,918 executives tracked by ExecPay. In other words, Curran earned more than 91.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 240 out of 2,918 | 92nd |
Division Manufacturing | 129 out of 1,608 | 92nd |
Major group Chemicals And Allied Products | 91 out of 901 | 90th |
Industry group Drugs | 89 out of 864 | 90th |
Industry Pharmaceutical Preparations | 56 out of 622 | 91st |
Source: SEC filing on April 12, 2024.
Curran's colleagues
We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2023.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020